|
|
|
|
LEADER |
02011nam a22003015i 4500 |
001 |
000294513 |
005 |
20210617081334.0 |
007 |
cr nn 008mamaa |
008 |
110504s2011 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781441984173
|
024 |
7 |
|
|a 10.1007/978-1-4419-8417-3
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Targeted Drug Strategies for Cancer and Inflammation /
|c edited by Ann L. Jackman, Christopher P. Leamon.
|
250 |
|
|
|a 1st ed. 2011.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2011.
|
300 |
|
|
|a XI, 254 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Biological Role, Properties and Therapeutic Applications of the Reduced Folate Carrier (RFC-SLC19A1) and the Proton-Coupled Folate Transporter (PCFT-SLC46A1) -- Folate Receptors and Therapeutic Applications -- Hormonal Control of Folate Receptor Genes -- Folate Receptor Targeted Radionuclide Imaging Agents -- Folate receptor targeted thymidylate synthase inhibitors -- Discovery of novel antifolate inhibitors of de novo purine nucleotide biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry -- Folate-receptor targeted cancer chemotherapy -- Anti-FR antibody generation and engineering: development of new therapeutic tools -- Folate Receptor Positive Macrophages: Cellular Targets for Imaging and Therapy of Inflammatory and Autoimmune Diseases -- Targeting Activated Macrophages via a Functional Folate Receptor for Potential Treatment of Autoimmune/Inflammatory Disorders.-.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
700 |
1 |
|
|a Jackman, Ann L.
|e editor.
|
700 |
1 |
|
|a Leamon, Christopher P.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|